| Literature DB >> 20600689 |
L M F Lucinda1, B J Vieira, T T Oliveira, R C S Sá, V M Peters, J E P Reis, M O Guerra.
Abstract
This study was aimed at investigating the anti-osteoporotic effects of the extract of Ginkgo biloba (EGb) in glucocorticoid-induced-osteoporosis. A significant reduction was observed in the percentage of the bone of the osteoporosis group in both the mandible and femur. The EGb group treated with 28 and 56 mg/Kg showed a significant increase in the percentage of trabecular bone (PTB) of the femur. The percentage of the alveolar bone of the mandible (PAB) had a significant increase with all doses of EGb. The treatment with EGb significantly reversed the loss of the PAB of the mandible and of the PTB of the femur.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20600689 DOI: 10.1016/j.fitote.2010.06.014
Source DB: PubMed Journal: Fitoterapia ISSN: 0367-326X Impact factor: 2.882